Application of NT-proBNP and BNP Measurements in Cardiac Care: A More Discerning Marker for the Detection and Evaluation of Heart Failure - Concepedia

Concepedia

Publication | Closed Access

Application of NT-proBNP and BNP Measurements in Cardiac Care: A More Discerning Marker for the Detection and Evaluation of Heart Failure

213

Citations

18

References

2004

Year

Yoshihiko Seino, Akio Ogawa, Teruyo Yamashita, Masato Fukushima, Kenichi Ogata, Hiroko Fukumoto, Teruo Takano

European Journal of Heart Failure

Abstract

NT-proBNP may be a more discerning marker for the detection and evaluation of heart failure than BNP.

References

	Year	Citations
Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure Alan S. Maisel, Padma Krishnaswamy, Richard M. Nowak, New England Journal of Medicine	2002	3.3K
Guidelines for the diagnosis and treatment of chronic heart failure W. Remme European Heart Journal Heart FailureChronic Heart FailureStructural Heart DiseaseCardiovascular DiseaseCardiac Care	2001	1.6K
ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure) Sharon A. Hunt, David W. Baker, Marshall H. Chin, Circulation	2001	1.4K
Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Gary S. Francis, Claude R. Benedict, David E. Johnstone, Circulation HypertensionHeart FailureCardiomyopathyCardiogenic ShockCardiovascular Disease	1990	1.4K
Biochemical detection of left-ventricular systolic dysfunction T. McDonagh, SD Robb, J.J. Morton, The Lancet CardiomyopathyHeart FailureBiochemical DetectionCardiovascular DiseasePhysiology	1998	972
B-Type Natriuretic Peptide and Clinical Judgment in Emergency Diagnosis of Heart Failure Peter A. McCullough, Richard M. Nowak, James McCord, Circulation	2002	881
Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care Martín Cowie, Allan D. Struthers, David A. Wood, The Lancet HypertensionHeart FailurePrimary CareNatriuretic PeptidesCardiovascular Disease	1997	875
N-Terminal Pro-B–Type Natriuretic Peptide and Long-Term Mortality in Acute Coronary Syndromes Torbjørn Omland, Anita Persson, Leong L. Ng, Circulation	2002	570
Comprehensive Guidelines for the Diagnosis and Treatment of Chronic Heart Failure Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology Willem J. Remme, Karl Swedberg European Journal of Heart Failure	2002	454
N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation Tomas Jernberg, Mats Stridsberg, Per Venge, Journal of the American College of Cardiology St-segment ElevationEarly Risk StratificationCardiovascular DiseaseNeurologyChest Pain	2002	342

Page 1